World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
27005
World Ranking
1494
National Ranking
752

Medicine

D-Index
82
Citations
27007
World Ranking
16031
National Ranking
8066

Overview

Joel D. Meyers was affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research work focused primarily on medicine, with particular contributions in the subfields of infectious diseases, hepatology, immunology, epidemiology, and oncology.

The scientist's main research topics included:

  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis Viruses Studies and Epidemiology
  • Immunotherapy and Immune Responses
  • Cytomegalovirus and herpesvirus research
  • Viral-associated cancers and disorders
  • Parvovirus B19 Infection Studies

Joel D. Meyers contributed to several research papers, including:

  • B-077 Comparison of SARS-CoV-2 Antibody Profile and Omicron-Specific Neutralizing Activity Before and After mRNA Booster Vaccines: Bivalent vs. Original Formulation (2023) published in Clinical Chemistry
  • B-100 Utilization and Performance of Monospot and Epstein-Barr Virus Antibody Profile Testing for Diagnosis of Infectious Mononucleosis in Adolescents and Adults (2024) published in Clinical Chemistry

The scientist frequently collaborated with other researchers, including:

  • Christine Schmotzer
  • Jaime H. Noguez
  • Anne Windau
  • Xiaoliang Yang
  • R Pontoni

The primary venue for Joel D. Meyers's publications was Clinical Chemistry, where they published at least two papers.

Best Publications

  • Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation

    Joel D. Meyers;Nancy Flournoy;E. Donnall Thomas

  • Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation—A Prospective, Randomized, Double-Blind Study

    M A Slavin;B Osborne;R Adams;M J Levenstein

  • Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.

    Pierre Reusser;Stanley R. Riddell;Joel D. Meyers;Philip D. Greenberg

  • GANCICLOVIR PROPHYLAXIS TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC MARROW TRANSPLANT

    James M. Goodrich;Raleigh A. Bowden;Lloyd Fisher;Claire Keller

  • Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation

    Goodrich Jm;Mori M;Gleaves Ca;Du Mond C

  • Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplants

    Elizabeth C. Reed;Raleigh A. Bowden;Paula S. Dandliker;Kathryn E. Lilleby

  • Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience

    J D Meyers;N Flournoy;E D Thomas

  • Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation

    R. A. Bowden;M. Sayers;N. Flournoy;B. Newton

  • Adenovirus Infections in Patients Undergoing Bone-Marrow Transplantation

    Anthony F. Shields;Anthony F. Shields;Anthony F. Shields;Robert C. Hackman;Robert C. Hackman;Robert C. Hackman;Kenneth H. Fife;Lawrence Corey;Lawrence Corey;Lawrence Corey

  • Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow Transplantation

    Joel D. Meyers;Joel D. Meyers;Joel D. Meyers;Elizabeth C. Reed;David H. Shepp;David H. Shepp;David H. Shepp;Mark Thornquist;Mark Thornquist;Mark Thornquist

  • Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

    Balfour Hh;Bean B;Laskin Ol;Ambinder Rf

  • An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant Center

    Robert D. Harrington;Thomas M. Hooton;Thomas M. Hooton;Robert C. Hackman;Robert C. Hackman;Gregory A. Storch;Gregory A. Storch

  • Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.

    David H. Shepp;Paula S. Dandliker;Paulo de Miranda;Thimysta C. Burnette

  • Infection with varicella- zoster virus after marrow transplantation

    Richard M. Locksley;Nancy Flournoy;Keith M. Sullivan;Joel D. Meyers

  • Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.

    Keith M. Sullivan;Kenneth J. Kopecky;Jane Jocom;Lyly Fisher

  • Herpes Simplex Virus Pneumonia: Clinical, Virologic, and Pathologic Features in 20 Patients

    Paul G. Ramsey;Kenneth H. Fife;Robert C. Hackman;Joel D. Meyers

  • Human Herpesvirus 6 in Lung Tissue from Patients with Pneumonitis after Bone Marrow Transplantation

    Richard W. Cone;Robert C. Hackman;Meei-Li W. Huang;Raleigh A. Bowden

  • Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.

    David H. Shepp;Paula S. Dandliker;Joel D. Meyers

  • Intravenous Acyclovir to Treat Mucocutaneous Herpes Simplex Virus Infection After Marrow Transplantation: A Double-Blind Trial

    James C. Wade;Barbara Newton;Colin McLAREN;Nancy Flournoy

  • Cytomegalovirus Excretion as a Predictor of Cytomegalovirus Disease after Marrow Transplantation: Importance of Cytomegalovirus Viremia

    Joel D. Meyers;Per Ljungman;Lloyd D. Fisher

Frequent Co-Authors

Robert C. Hackman
Robert C. Hackman University of Washington School of Medicine
E. Donnall Thomas
E. Donnall Thomas University of Washington
Keith M. Sullivan
Keith M. Sullivan Duke University
Jean E. Sanders
Jean E. Sanders Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
George B. McDonald
George B. McDonald University of Washington
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Buckner Cd
Buckner Cd National Cancer Institute
Kristine Doney
Kristine Doney Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, complementary healthcare degrees can open diverse career opportunities. Nursing programs, especially specialized tracks, can be a valuable choice. For example, exploring acnp programs offers a pathway to become an Acute Care Nurse Practitioner, which involves advanced clinical roles often related to immunological care.

Many students begin their nursing careers through accelerated options. The accelerated rn to np programs provide busy professionals a faster route from registered nurse to nurse practitioner, allowing for advanced practice in fields connected to Immunology. Meanwhile, non-nurses considering a shift into healthcare can benefit from online absn programs for non nurses, designed to quickly prepare students for registered nursing roles.

Understanding regional salary differences is crucial for career planning in this field. The dnp salary by state resource helps prospective Doctor of Nursing Practice holders assess earning potential across the USA, which is essential when choosing where to study and work in Immunology-related nursing specialties.

Best Scientists Citing Joel D. Meyers